| Literature DB >> 28698999 |
Roy A Willems1, Ilse Mesters2, Lilian Lechner3, Iris M Kanera3, Catherine A W Bolman3.
Abstract
PURPOSE: The web-based computer-tailored Kanker Nazorg Wijzer (Cancer Aftercare Guide) supports cancer survivors with psychosocial issues during cancer recovery. The current study investigates whether the 6-month effects in increasing emotional and social functioning and reducing depression and fatigue hold at 12 months from baseline. Moreover, it explores whether patient characteristics moderate the 6- and 12-month intervention effectiveness.Entities:
Keywords: Computer tailoring; Psycho-oncology; RCT; Self-management; Survivorship; eHealth
Mesh:
Year: 2017 PMID: 28698999 PMCID: PMC5671537 DOI: 10.1007/s11764-017-0625-0
Source DB: PubMed Journal: J Cancer Surviv ISSN: 1932-2259 Impact factor: 4.442
Baseline demographic and disease-related characteristics (n = 462)
| Control | Intervention | |
|---|---|---|
| Demographic characteristics | ||
| Gender (% women) | 80.5% | 79.2% |
| Age (years) (mean ± | 56.16 ± 11.33 | 55.59 ± 11.46 |
| Relationship status (% partner) | 79.7% | 83.5% |
| Education level (%) | ||
| Low | 42.0% | 32.9% |
| Medium | 30.3% | 32.9% |
| High | 27.7% | 34.2% |
| Modal income (%) | ||
| Below modal income | 18.2% | 12.1% |
| Approximately modal income | 33.8% | 36.4% |
| Above modal income | 48.1% | 51.5% |
| Employment status (% employed) | 48.1% | 52.8% |
| Disease-related characteristics | ||
| BMI (mean ± | 26.45 ± 4.86 | 25.96 ± 4.96 |
| Cancer type | ||
| Breast | 71.0% | 70.1% |
| Bladder | 0.4% | 0.4% |
| Colorectal | 15.6% | 12.6% |
| Esophageal | 1.3% | 1.3% |
| Gynecologic | 2.6% | 3.9% |
| Hematologic | 6.1% | 5.2% |
| Kidney | 0.4% | 1.3% |
| Liver | 0.4% | 0% |
| Lung | 0% | 2.2% |
| Prostate | 0.9% | 1.3% |
| Stomach | 0.9% | 0.4% |
| Testicular | 0.4% | 0.9% |
| Thyroid | 0% | 0.4% |
| Had cancer before (% yes) | 10.0% | 10.4% |
| Treatment type | ||
| Surgery | 13.4% | 12.1% |
| Chemotherapy | 4.3% | 3.5% |
| Radiotherapy | 1.3% | 0.4% |
| Chemotherapy and radiotherapy | 0.4% | 0.4% |
| Surgery and chemotherapy | 20.8% | 26.4% |
| Surgery and radiotherapy | 12.3% | 19.9% |
| Surgery, chemotherapy, and radiotherapy | 46.8% | 37.2% |
| Time since last treatment (weeks) (mean ± | 23.44 ± 12.90 | 25.06 ± 13.49 |
| Participation in support program (% yes) | 61.0% | 62.8% |
| Comorbid condition (% yes) | 27.3% | 26.8% |
Fig. 1Flow diagram of the study
Means and SD’s of outcomes at baseline and 6 and 12 months
| Baseline | 6 months | 12 months | |
|---|---|---|---|
| Emotional functioning | |||
| Control | 79.83 ± 21.49 | 81.00 ± 20.31 | 81.90 ± 19.61 |
| Intervention | 77.78 ± 22.60 | 83.78 ± 17.76 | 83.58 ± 20.58 |
| Social functioning | |||
| Control | 82.03 ± 22.53 | 87.25 ± 19.45 | 87.86 ± 19.00 |
| Intervention | 79.80 ± 21.04 | 90.07 ± 16.86 | 88.29 ± 19.52 |
| Depression | |||
| Control | 3.44 ± 3.45 | 3.53 ± 3.67 | 3.21 ± 3.47 |
| Intervention | 3.65 ± 3.26 | 2.82 ± 3.06 | 2.90 ± 2.99 |
| Fatigue | |||
| Control | 65.20 ± 28.25 | 61.77 ± 28.15 | 59.87 ± 27.51 |
| Intervention | 64.55 ± 26.46 | 55.90 ± 26.72 | 58.83 ± 29.14 |
Fig. 2Line graphs of the outcome scores at baseline and 6 and 12 months after baseline. Vertical bars represent the 95% CI of the mean
Results of the multilevel analyses testing the effectiveness of the KNW on emotional and social functioning, depression, and fatigue at 6 and 12 months from baseline
| Mixed models ( | Imputed data ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| SE | 95% CI |
|
|
|
| SE | 95% CI |
| ||
| Emotional functioning | |||||||||||
| 6 months | Crude | 3.21 | 1.55 | 0.18–6.25 | .038 | .038 | −0.15 [−0.34–0.05] | 2.35 | 1.59 | −0.77–5.48 | .139 |
| Adjusted | 3.04 | 1.54 | 0.02–6.07 | .049 | .049 | 1.92 | 1.57 | −1.15–5.00 | .221 | ||
| 12 months | Crude | 2.79 | 1.60 | −0.35–5.93 | .081 | .661 | −0.08 [−0.28–0.12] | 0.27 | 1.67 | −3.01–3.56 | .871 |
| Adjusted | 2.65 | 1.60 | −0.47–5.78 | .096 | .384 | −0.16 | 1.66 | −3.43–3.11 | .923 | ||
| Social functioning | |||||||||||
| 6 months | Crude | 3.64 | 1.65 | 0.41–6.87 | .027 | .037 | −0.15 [−0.35–0.04] | 1.37 | 1.83 | −2.22–4.96 | .453 |
| Adjusted | 3.50 | 1.61 | 0.35–6.66 | .030 | .048 | 1.03 | 1.78 | −2.45–4.53 | .562 | ||
| 12 months | Crude | 1.38 | 1.71 | −1.97–4.73 | .421 | .661 | −0.02 [−0.22–0.18] | −3.01 | 1.81 | −6.57–0.54 | .096 |
| Adjusted | 1.31 | 1.67 | −1.97 – 4.59 | .435 | .580 | −3.36 | 1.76 | −6.80–0.10 | .057 | ||
| Depression | |||||||||||
| 6 months | Crude | −0.51 | 0.20 | −0.90–−0.11 | .011 | .037 | 0.21 [0.01–0.40] | −0.51 | 0.21 | −0.93–−0.10 | .014 |
| Adjusted | −0.46 | 0.20 | −0.86–−0.07 | .021 | .048 | −0.41 | 0.21 | −0.82–−0.00 | .049 | ||
| 12 months | Crude | −0.30 | 0.21 | −0.70–0.10 | .145 | .661 | 0.10 [−0.11–0.30] | −0.19 | 0.21 | −0.60–0.23 | .375 |
| Adjusted | −0.25 | 0.21 | −0.66 – 0.16 | .227 | .454 | −0.09 | 0.21 | −0.50–0.33 | .684 | ||
| Fatigue | |||||||||||
| 6 months | Crude | −4.36 | 1.98 | −8.23–−0.48 | .028 | .037 | 0.21 [0.02–0.41] | −4.84 | 1.96 | −8.68–−1.00 | .014 |
| Adjusted | −4.04 | 1.92 | −7.82–−0.26 | .036 | .048 | −4.12 | 1.91 | −7.87–−0.39 | .030 | ||
| 12 months | Crude | −1.42 | 2.03 | −5.41–2.56 | .482 | .661 | 0.04 [−0.17–0.24] | −0.71 | 2.02 | −4.68–3.26 | .725 |
| Adjusted | −1.01 | 1.98 | −4.90–2.88 | .611 | .661 | −0.00 | 1.98 | −3.88–3.88 | 1.000 | ||
p gives the p-values corrected for multiple testing using false discovery rate [44]. Correction for multiple testing was carried out in four sets: (1) crude analyses at 6 months, (2) adjusted analyses at 6 months, (3) crude analyses at 12 months, and (4) adjusted analyses at 12 months